Cargando…

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies

In 2019, the novel coronavirus, SARS-CoV-2, caused a worldwide pandemic, affecting more than 630 million individuals and causing 6.5 million deaths. In the general population, poorer outcomes have been associated with older age, chronic lung and cardiovascular diseases, and lymphopenia, highlighting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milota, Tomas, Smetanova, Jitka, Bartunkova, Jirina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860966/ https://www.ncbi.nlm.nih.gov/pubmed/36678457 http://dx.doi.org/10.3390/pathogens12010109

Ejemplares similares

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?
por: Klojdová, Iveta, et al.
Publicado: (2023)

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs
por: Smetanova, Jitka, et al.
Publicado: (2022)

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients
por: Smetanova, Jitka, et al.
Publicado: (2022)

Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn’s disease
por: Parackova, Zuzana, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109
por: Özdemir, Öner
Publicado: (2023)

The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy
por: Votava, Michal, et al.
Publicado: (2022)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019
por: Anderson, Blake, et al.
Publicado: (2021)

Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
por: Ozaniak, Andrej, et al.
Publicado: (2021)

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
por: Fučíková, Jitka, et al.
Publicado: (2011)

Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency
por: Rosenthal, Jamie A., et al.
Publicado: (2023)

Prediction of adverse clinical outcomes in patients with coronavirus disease 2019
por: Shi, Si, et al.
Publicado: (2020)

Clinical Outcomes of Acute Pancreatitis in Patients With Coronavirus Disease 2019
por: Dirweesh, Ahmed, et al.
Publicado: (2020)

Clinical significance of antinuclear antibody positivity in patients with severe coronavirus disease 2019
por: Park, Soo Hyun, et al.
Publicado: (2023)

Novel coronavirus disease 2019 and perinatal outcomes
por: Irani, Morvarid, et al.
Publicado: (2020)

Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy
por: Taborska, Pavla, et al.
Publicado: (2021)

Coronavirus disease 2019 antibody testing in pregnancy
por: Zullo, Fabrizio, et al.
Publicado: (2020)

Clinical Manifestations of Coronavirus Disease 2019
por: Kutsuna, Satoshi
Publicado: (2021)

Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies
por: Foshati, Sahar, et al.
Publicado: (2022)

Hemodialysis patients with coronavirus disease 2019: reduced antibody response
por: Beppu, Hiroko, et al.
Publicado: (2021)

Clinical implications of coronavirus disease 2019 in neonates
por: Kim, Do-Hyun
Publicado: (2021)

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study
por: Milota, Tomas, et al.
Publicado: (2022)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors
por: Farooque, Imran, et al.
Publicado: (2021)

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials
por: Buchman, Timothy G., et al.
Publicado: (2021)

Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency
por: Squire, Jacqueline, et al.
Publicado: (2021)

Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
por: Yetmar, Zachary A, et al.
Publicado: (2022)

The broad spectrum of lung diseases in primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2018)

Pulmonary Rehabilitation in Coronavirus Disease 2019 Patients
por: Menekşeoğlu, Ahmet Kıvanç, et al.
Publicado: (2022)

Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
por: Knight, Dacre, et al.
Publicado: (2021)

Clinical outcomes of coronavirus disease 2019 in liver transplant recipients
por: Shafiq, Muhammad, et al.
Publicado: (2022)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Tumoral and paratumoral NK cells and CD8(+) T cells of esophageal carcinoma patients express high levels of CD47
por: Strizova, Zuzana, et al.
Publicado: (2020)

Coronavirus disease 2019 and the natural agents: Is there a role for the primary care?
por: Alharthi, Manal O., et al.
Publicado: (2021)

Epidemiology and clinical features of coronavirus disease 2019 in children
por: Choi, Soo-Han, et al.
Publicado: (2020)

Coronavirus disease 2019 in children: Clinical & epidemiological implications
por: Kuttiatt, Vijesh Sreedhar, et al.
Publicado: (2020)

Pediatric Coronavirus Disease 2019: Clinical Features and Management
por: Sahi, Puneet Kaur, et al.
Publicado: (2021)

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study
por: Liao, Xuejiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2o28rdcglrudtrgm76hta0dl1u